The importance of children and young person involvement in scoping the need for a paediatric glucocorticoid-associated patient reported outcome measure

BACKGROUND: For many children and young people (CYP) with paediatric rheumatic conditions, glucocorticoid medications and their associated side-effects have a substantial impact on disease experience. Whilst there are physician-rated measures of glucocorticoid toxicity, no parallel patient reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhal, S., Smith, E. M. D., Roper, L., Pain, C. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568975/
https://www.ncbi.nlm.nih.gov/pubmed/36243873
http://dx.doi.org/10.1186/s41927-022-00312-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568975/
https://www.ncbi.nlm.nih.gov/pubmed/36243873
http://dx.doi.org/10.1186/s41927-022-00312-9

Ejemplares similares